Products for Research Use Only

PJ34

CAT: 0804-HY-13688A-02Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-13688A-02Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PJ34 is a potent specific inhibitor of PARPl/2 with IC50 of 110 nM and 86 nM, respectively.
CAS Number
344458-19-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pj34.html
Purity
98.11
Solubility
DMSO : 25 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC(C=C1C2=C3C=CC=C2)=CC=C1NC3=O)CN(C)C
Molecular Formula
C17H17N3O2
Molecular Weight
295.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Iwashita A, et al. A novel and potent poly (ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3- (4-phenyl-3,6-dihydro-1 (2H) -pyridinyl) propyl]-4 (3H) -quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J Ph|[2]Haddad M, et al. Anti-inflammatory effects of PJ34, a poly (ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol. 2006 Sep;149 (1) :23-30.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PARP; PARP1; PARP2
Citation 01
Antioxidants (Basel) . 2024 Apr 26, 13 (5), 525.|Antioxidants (Basel) . 2024 Apr 26;13 (5) :525.|Apoptosis. 2021 Dec;26 (11-12) :600-611.|Autophagy. 2025 May 8:1-24.|Biochim Biophys Acta Mol Basis Dis. 2024 Apr 22;1870 (5) :167190.|Bioorg Chem. 2024 Jun:147:107412.|bioRxiv. 2023 Oct 4.|bioRxiv. 2024 Sep 19:2024.09.19.613696.|bioRxiv. 2025 March 26.|Cancer Lett. 2021 Nov 1:520:26-37.|Cell Mol Life Sci. 2025 Oct 25;82 (1) :363.|Free Radic Biol Med. 2022 Feb 1:179:1-10.|J Enzyme Inhib Med Chem. 2025 Dec;40 (1) :2501743.|J Invest Dermatol. 2024 May 30:S0022-202X (24) 00384-1.|J Transl Med. 2024 Dec 27;22 (1) :1153.|J Virol. 2021 Jul 26;95 (16) :e0076021.|Mol Med Rep. 2024 Jun;29 (6) :102.|Nat Aging. 2024 May 9.|Norges teknisk-naturvitenskapelige universitet. 2024.|Norges teknisk-naturvitenskapelige universitet. 2025.|Nottingham Trent University. 2023 Sep 12.|Part Fibre Toxicol. 2020 Jun 8;17 (1) :23. |Patent. US20180263995A1.|Proc Natl Acad Sci U S A. 2023 Mar 28;120 (13) :e2213857120.|Regen Ther. 2023 Nov 10:24:592-601.|Research Square Print. 2022.|Sci Signal. 2023 Jan 17;16 (768) :eabh1083.|Acta Biomater. 2022 Jul 15:147:327-341.|Anim Cells Syst. 2022 Aug 3;26 (4) :192-202.|J Mol Med (Berl) . 2019 Aug;97 (8) :1183-1193.|Sci Rep. 2017 May 23;7 (1) :2268.

Chemical Information

PJ-34

PJ34 is a member of the class of phenanthridines that is 5,6-dihydrophenanthridine substituted at positions 2 and 6 by (N,N-dimethylglycyl)amino and oxo groups, respectively. It is a potent inhibitor of poly(ADP-ribose) polymerases PARP1 and PARP2 (IC50 of 110 nM and 86 nM, respectively) and exhibits anti-cancer, cardioprotective and neuroprotective properties. It has a role as an antiatherosclerotic agent, an antineoplastic agent, an angiogenesis inhibitor, an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor, a neuroprotective agent, an anti-inflammatory agent, an apoptosis inducer and a cardioprotective agent. It is a secondary carboxamide, a tertiary amino compound and a member of phenanthridines. It is a conjugate base of a PJ34(1+).

CAS Number344458-19-1
PubChem CID4858
IUPAC Name2-(dimethylamino)-N-(6-oxo-5H-phenanthridin-2-yl)acetamide
Molecular FormulaC17H17N3O2
Molecular Weight295.34
XLogP1.7
Topological Polar Surface Area61.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Heavy Atom Count22
Formal Charge0
Complexity438
SMILES
CN(C)CC(=O)NC1=CC2=C(C=C1)NC(=O)C3=CC=CC=C32
InChI
InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22)
InChIKey
UYJZZVDLGDDTCL-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of PJ-34
CAS: 344458-19-1
CID: 4858
Formula: C17H17N3O2
MW: 295.34
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight295.34
XLogP31.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass295.132076794
Monoisotopic Mass295.132076794
Topological Polar Surface Area61.4 Ų
Heavy Atom Count22
Formal Charge0
Complexity438
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Popular Products